|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.8 TWD | -0.42% |
|
-6.11% | -30.91% |
| 04-18 | Sunny Pharmtech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Sunny Pharmtech Inc.(TPEX:6676) added to S&P Global BMI Index | CI |
Sunny Pharmtech Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 359.59 million compared to TWD 241 million a year ago. Net loss was TWD 170.24 million compared to TWD 174.79 million a year ago.
Basic loss per share from continuing operations was TWD 1.23 compared to TWD 1.31 a year ago. Diluted loss per share from continuing operations was TWD 1.23 compared to TWD 1.31 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -30.91% | 109M | |
| +61.53% | 856B | |
| +38.95% | 631B | |
| -3.66% | 359B | |
| +15.06% | 325B | |
| +9.18% | 297B | |
| +5.89% | 234B | |
| +16.53% | 226B | |
| +15.67% | 177B | |
| +2.47% | 165B |
SUNNY PHARMTECH INC. 
